Onconetix

Cincinnati, United States

Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.

$12.9M raised

Sep 2025

Post-IPO Equity

Top Investors

CincyTech

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Onconetix raised?

Onconetix has raised $12.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2025.

Who are Onconetix's investors?

Onconetix's investors include CincyTech.

Where is Onconetix headquartered?

Onconetix is headquartered in Cincinnati, United States.

What does Onconetix do?

Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.

What stage is Onconetix at?

Onconetix is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 22, 2025.

MLA

"Onconetix — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/onconetix. Accessed July 1, 2026.

APA

VCBacked. (2025). Onconetix — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/onconetix

Wikipedia (cite web)

{{cite web |title=Onconetix — Funding & Investors |url=https://www.vcbacked.co/company/onconetix |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 22, 2025.